Aurion Biotech files for IPO amid legal battle with Alconnews2025-01-27T14:48:51+00:00January 27th, 2025|Endpoints News|
Purdue, Sacklers reach new $7.4B opioid settlement after SCOTUS rejectionnews2025-01-23T20:01:12+00:00January 23rd, 2025|Endpoints News|
Vanda loses constitutional fight over FDA’s drug talks with competitorsnews2025-01-22T20:31:17+00:00January 22nd, 2025|Endpoints News|
RFK Jr. says he’ll divest interests in CRISPR Therapeutics if confirmed for HHS chiefnews2025-01-22T16:50:52+00:00January 22nd, 2025|Endpoints News|
Renewed mifepristone fight will test Trump’s abortion stancenews2025-01-21T21:32:32+00:00January 21st, 2025|Endpoints News|
Sage sues Biogen days after $469M buyout offernews2025-01-17T21:12:51+00:00January 17th, 2025|Endpoints News|
What Trump’s CMS can and can’t change with the second round of drug price negotiationsnews2025-01-17T18:17:16+00:00January 17th, 2025|Endpoints News|
Teva says it has a ‘unique position’ in latest IRA challengenews2025-01-16T20:20:48+00:00January 16th, 2025|Endpoints News|
HHS blasts Boehringer’s drug price case, reveals new details on Jardiance talksnews2025-01-16T20:09:36+00:00January 16th, 2025|Endpoints News|
DC appeals court halts launch of generic to Novartis’ heart drugnews2025-01-16T18:38:11+00:00January 16th, 2025|Endpoints News|
